EMILY GRISNIK: Open Payments
NPI 1144679416 · LEONARDTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$45,659 in 292 payments from 25 companies in 2025. Trend: 2023 $5,943 · 2024 $6,489 · 2025 $45,659
Honoraria: $20,900Travel & lodging: $9,764Consulting: $7,618Food & beverage: $7,269Education: $109
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 70 | $34,173 |
| Janssen Biotech, Inc. | 17 | $1,976 |
| ABBVIE INC. | 29 | $1,720 |
| Regeneron Healthcare Solutions, Inc. | 10 | $1,507 |
| Botanix SB Inc | 14 | $1,105 |
| UCB, Inc. | 10 | $892 |
| LEO Pharma Inc. | 37 | $747 |
| Galderma Laboratories, L.P. | 17 | $640 |
| Journey Medical Corporation | 3 | $589 |
| Incyte Corporation | 14 | $473 |
Products named: VTAMA, TREMFYA, DUPIXENT, RINVOQ, SOFDRA, Bimzelx, NEMLUVIO, OPZELURA.
Industry payments across MD — which companies pay providers there.
